MedPath

Pretreatment with Misoprostol before vacuum aspiration versus MVA: Double blind RCT- A pilot study

Phase 3
Registration Number
CTRI/2009/091/000008
Lead Sponsor
Ministry of health & family Welfare,Delhi
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
480
Inclusion Criteria

INCLUSION CRITERIA
?Women seeking medical termination of pregnancy
?Gestational age <10 completed wks of pregnancy
?Willing to participate in the study, give and sign a consent form
?Has a normal single intrauterine pregnancy less than 10 completed weeks on the day of vacuum aspiration/MVA
?Agrees to return for a scheduled follow up visit 7-14 days after the surgery.

Exclusion Criteria

EXCLUSION CRITERIA
?For the study previous caeserean
?Allergy to misoprostol
?History of or evidence of disorders C/I to use of PGs

-Mitral stenosis
-Glaucoma
-sickle cell anaemia
-diastolic BP>90 mms Hg
-Bronchial asthma
-systolic BP<90 mm Hg
-anemia (Hb<100 g/l) or any coagulation disorder.
-Chronic medical disorder that requires special care or treatment or precautions
-C/ I steroid
-anticoagulant therapy

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath